SCINAI IMMUNOTHERAPEUTICS LTD. Investment Banking Revenue
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Investment Banking Revenue of EUR 250.00 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InvestmentBankingRevenue · last filed 2026-04-01
- 2025-06-30: Investment Banking Revenue 6 month 250.00M EUR.
- 2017-06-19: Investment Banking Revenue 20.00K EUR; Investment Banking Revenue as first filed 20.00M EUR.
EUR
| Period end | Investment Banking Revenue | Investment Banking Revenue as first filed | Investment Banking Revenue 6 month |
|---|---|---|---|
| 2025-06-30 | 250.00M EUR 6-K · filed 2025-09-02 | ||
| 2017-06-19 | 20.00K EUR 20-F · filed 2026-04-01 | 20.00M EUR 20-F · filed 2024-05-15 |
USD
| Period end | Investment Banking Revenue | Investment Banking Revenue 6 month |
|---|---|---|
| 2025-06-30 | $293.00M 6-K · filed 2025-09-02 | |
| 2017-06-19 | $22.42M 20-F · filed 2026-04-01 |